PRVL

Prevail Therapeutics Inc.CIK 1714798 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for PRVL PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for PRVL

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Tyto Acquisition Corp	10% Owner	1	$771.41M	$0	2021-01-22
Carson William H.	Director	2	$0	$0	2021-01-22
Schwartz Kira M.	General Counsel	2	$0	$0	2021-01-22
Sheng Morgan	Director	4	$0	$0	2021-01-22
Kaplan Brett	Chief Financial Officer	4	$0	$0	2021-01-22
Minkow Emily	Chief Business Officer	8	$0	$0	2021-01-22
Dai Yong	Chief Technology Officer	4	$0	$0	2021-01-22
Sevigny Jeffrey	Chief Medical Officer	4	$0	$0	2021-01-22
Abeliovich Asa	President & CEO	10	$0	$0	2021-01-22
Hefti Franz	Chief Development Officer	4	$0	$0	2021-01-22
OrbiMed Capital GP VI LLC	Director, 10% Owner	1	$0	$0	2021-01-22
Nussbaum Ran	Director	3	$0	$0	2021-01-22
Nader Francois	Director	7	$0	$0	2021-01-22
Thompson Peter A.	Director, 10% Owner	8	$15.00M	$0	2021-01-22
Adams Timothy M	Director	3	$0	$0	2021-01-22
GORDON CARL L	Director, 10% Owner	8	$15.00M	$0	2021-01-22
ORBIMED ADVISORS LLC	Director, 10% Owner	5	$15.00M	$0	2019-06-24

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Thompson Peter A.	Director, 10% Owner	D To issuer deriv	2021-01-22	2021-01-26	17,000	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	D To issuer deriv	2021-01-22	2021-01-26	17,000	—	$0	0	SEC↗
Nussbaum Ran	Director	D To issuer deriv	2021-01-22	2021-01-26	17,000	—	$0	0	SEC↗
Sheng Morgan	Director	D To issuer deriv	2021-01-22	2021-01-26	17,000	—	$0	0	SEC↗
Sheng Morgan	Director	D To issuer deriv	2021-01-22	2021-01-26	20,000	—	$0	0	SEC↗
Sevigny Jeffrey	Chief Medical Officer	D To issuer deriv	2021-01-22	2021-01-26	89,000	—	$0	0	SEC↗
Sevigny Jeffrey	Chief Medical Officer	D To issuer deriv	2021-01-22	2021-01-26	122,439	—	$0	0	SEC↗
Sevigny Jeffrey	Chief Medical Officer	D To issuer deriv	2021-01-22	2021-01-26	400,342	—	$0	0	SEC↗
Schwartz Kira M.	General Counsel	D To issuer deriv	2021-01-22	2021-01-26	100,000	—	$0	0	SEC↗
Nader Francois	Director	D To issuer deriv	2021-01-22	2021-01-26	32,000	—	$0	0	SEC↗
Nader Francois	Director	D To issuer deriv	2021-01-22	2021-01-26	17,000	—	$0	0	SEC↗
Nader Francois	Director	D To issuer deriv	2021-01-22	2021-01-26	133,447	—	$0	0	SEC↗
Minkow Emily	Chief Business Officer	D To issuer deriv	2021-01-22	2021-01-26	149,000	—	$0	0	SEC↗
Minkow Emily	Chief Business Officer	D To issuer deriv	2021-01-22	2021-01-26	104,895	—	$0	0	SEC↗
Minkow Emily	Chief Business Officer	D To issuer deriv	2021-01-22	2021-01-26	108,854	—	$0	0	SEC↗
Minkow Emily	Chief Business Officer	D To issuer deriv	2021-01-22	2021-01-26	54,000	—	$0	0	SEC↗
Kaplan Brett	Chief Financial Officer	D To issuer deriv	2021-01-22	2021-01-26	95,000	—	$0	0	SEC↗
Kaplan Brett	Chief Financial Officer	D To issuer deriv	2021-01-22	2021-01-26	64,565	—	$0	0	SEC↗
Kaplan Brett	Chief Financial Officer	D To issuer deriv	2021-01-22	2021-01-26	347,004	—	$0	0	SEC↗
Hefti Franz	Chief Development Officer	D To issuer deriv	2021-01-22	2021-01-26	62,200	—	$0	0	SEC↗
Hefti Franz	Chief Development Officer	D To issuer deriv	2021-01-22	2021-01-26	59,844	—	$0	0	SEC↗
Hefti Franz	Chief Development Officer	D To issuer deriv	2021-01-22	2021-01-26	266,895	—	$0	0	SEC↗
Dai Yong	Chief Technology Officer	D To issuer deriv	2021-01-22	2021-01-26	43,500	—	$0	0	SEC↗
Dai Yong	Chief Technology Officer	D To issuer deriv	2021-01-22	2021-01-26	126,567	—	$0	0	SEC↗
Dai Yong	Chief Technology Officer	D To issuer deriv	2021-01-22	2021-01-26	200,172	—	$0	0	SEC↗
Carson William H.	Director	D To issuer deriv	2021-01-22	2021-01-26	34,000	—	$0	0	SEC↗
Adams Timothy M	Director	D To issuer deriv	2021-01-22	2021-01-26	32,400	—	$0	0	SEC↗
Adams Timothy M	Director	D To issuer deriv	2021-01-22	2021-01-26	17,000	—	$0	0	SEC↗
Abeliovich Asa	President & CEO	D To issuer deriv	2021-01-22	2021-01-26	250,000	—	$0	0	SEC↗
Abeliovich Asa	President & CEO	D To issuer deriv	2021-01-22	2021-01-26	1,329,219	—	$0	0	SEC↗
Abeliovich Asa	President & CEO	D To issuer deriv	2021-01-22	2021-01-26	178,681	—	$0	0	SEC↗
Tyto Acquisition Corp	10% Owner	P Buy	2021-01-22	2021-01-22	34,284,789	$22.50	$771.41M	100	SEC↗
Thompson Peter A.	Director, 10% Owner	U Tender	2021-01-22	2021-01-26	13,822,463	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	U Tender	2021-01-22	2021-01-26	13,822,463	—	$0	0	SEC↗
Nussbaum Ran	Director	U Tender	2021-01-22	2021-01-26	1,576,881	—	$0	0	SEC↗
Nader Francois	Director	U Tender	2021-01-22	2021-01-26	23,747	—	$0	0	SEC↗
Minkow Emily	Chief Business Officer	U Tender	2021-01-22	2021-01-26	13,000	—	$0	0	SEC↗
Abeliovich Asa	President & CEO	U Tender	2021-01-22	2021-01-26	2,385,756	—	$0	0	SEC↗
OrbiMed Capital GP VI LLC	Director, 10% Owner	U Tender	2021-01-22	2021-01-26	13,822,463	—	$0	0	SEC↗
Abeliovich Asa	President & CEO	M Exercise deriv	2020-12-30	2020-12-31	120,537	—	$0	178,681	SEC↗
Abeliovich Asa	President & CEO	M Exercise deriv	2020-12-30	2020-12-31	5,256	—	$0	1,329,219	SEC↗
Abeliovich Asa	President & CEO	M Exercise	2020-12-30	2020-12-31	5,256	$0.18	$946	2,354,256	SEC↗
Abeliovich Asa	President & CEO	M Exercise	2020-12-30	2020-12-31	120,537	$10.26	$1.24M	2,474,793	SEC↗
Abeliovich Asa	President & CEO	F Tax w/h	2020-12-30	2020-12-31	89,037	$23.02	$2.05M	2,385,756	SEC↗
Carson William H.	Director	A Award deriv	2020-09-09	2020-09-11	34,000	—	$0	34,000	SEC↗
Nader Francois	Director	A Award deriv	2020-06-17	2020-06-19	17,000	—	$0	17,000	SEC↗
Adams Timothy M	Director	A Award deriv	2020-06-17	2020-06-19	17,000	—	$0	17,000	SEC↗
GORDON CARL L	Director, 10% Owner	A Award deriv	2020-06-17	2020-06-19	17,000	—	$0	17,000	SEC↗
Nussbaum Ran	Director	A Award deriv	2020-06-17	2020-06-19	17,000	—	$0	17,000	SEC↗
Sheng Morgan	Director	A Award deriv	2020-06-17	2020-06-19	17,000	—	$0	17,000	SEC↗
Thompson Peter A.	Director, 10% Owner	A Award deriv	2020-06-17	2020-06-19	17,000	—	$0	17,000	SEC↗
Schwartz Kira M.	General Counsel	A Award deriv	2020-06-02	2020-06-03	100,000	—	$0	100,000	SEC↗
Sevigny Jeffrey	Chief Medical Officer	A Award deriv	2020-02-19	2020-03-11	89,000	—	$0	89,000	SEC↗
Abeliovich Asa	President & CEO	A Award deriv	2020-02-19	2020-03-11	250,000	—	$0	250,000	SEC↗
Kaplan Brett	Chief Financial Officer	A Award deriv	2020-02-19	2020-03-11	95,000	—	$0	95,000	SEC↗
Minkow Emily	Chief Business Officer	A Award deriv	2020-02-19	2020-03-11	54,000	—	$0	54,000	SEC↗
Hefti Franz	Chief Development Officer	A Award deriv	2020-02-19	2020-03-11	62,200	—	$0	62,200	SEC↗
Dai Yong	Chief Technology Officer	A Award deriv	2020-02-19	2020-03-11	43,500	—	$0	43,500	SEC↗
Minkow Emily	Chief Business Officer	M Exercise deriv	2019-12-24	2020-03-11	13,000	—	$0	149,000	SEC↗
Minkow Emily	Chief Business Officer	M Exercise	2019-12-24	2020-03-11	13,000	$0.18	$2.3K	13,000	SEC↗
Sheng Morgan	Director	A Award deriv	2019-11-15	2019-11-18	20,000	—	$0	20,000	SEC↗
Nader Francois	Director	C Conversion deriv	2019-06-24	2019-06-25	23,747	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	6,399,000	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	1,011,499	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	3,099,612	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	3,099,612	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	1,011,499	—	$0	0	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	6,399,000	—	$0	0	SEC↗
Thompson Peter A.	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	6,399,000	—	$0	0	SEC↗
Thompson Peter A.	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	3,099,612	—	$0	0	SEC↗
Thompson Peter A.	Director, 10% Owner	C Conversion deriv	2019-06-24	2019-06-26	1,011,499	—	$0	0	SEC↗
Nader Francois	Director	C Conversion	2019-06-24	2019-06-25	23,747	—	$0	23,747	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion	2019-06-24	2019-06-26	10,510,111	—	$0	12,940,111	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2019-06-24	2019-06-26	882,352	$17.00	$15.00M	13,822,463	SEC↗
GORDON CARL L	Director, 10% Owner	C Conversion	2019-06-24	2019-06-26	10,510,111	—	$0	12,940,111	SEC↗
GORDON CARL L	Director, 10% Owner	P Buy	2019-06-24	2019-06-26	882,352	$17.00	$15.00M	13,822,463	SEC↗
Thompson Peter A.	Director, 10% Owner	P Buy	2019-06-24	2019-06-26	882,352	$17.00	$15.00M	13,822,463	SEC↗
Thompson Peter A.	Director, 10% Owner	C Conversion	2019-06-24	2019-06-26	10,510,111	—	$0	12,940,111	SEC↗